Search Results - "Gleave, Emma S"
-
1
Single-molecule studies contrast ordered DNA replication with stochastic translesion synthesis
Published in eLife (06-12-2017)“…High fidelity replicative DNA polymerases are unable to synthesize past DNA adducts that result from diverse chemicals, reactive oxygen species or UV light. To…”
Get full text
Journal Article -
2
A structural analysis of the AAA+ domains in Saccharomyces cerevisiae cytoplasmic dynein
Published in Journal of structural biology (01-06-2014)“…Dyneins are large protein complexes that act as microtubule based molecular motors. The dynein heavy chain contains a motor domain which is a member of the…”
Get full text
Journal Article -
3
Insights into dynein motor domain function from a 3.3-Å crystal structure
Published in Nature structural & molecular biology (01-05-2012)“…Dynein is a molecular motor involved in many cellular functions. The motor domain of dynein contains six AAA+ domains forming a ring that interacts with the…”
Get full text
Journal Article -
4
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRASG12C with Demonstrable CNS Penetration
Published in Journal of medicinal chemistry (13-07-2023)“…The glycine to cysteine mutation at codon 12 of Kirsten rat sarcoma (KRAS) represents an Achilles heel that has now rendered this important GTPase druggable…”
Get full text
Journal Article -
5
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRAS G12C with Demonstrable CNS Penetration
Published in Journal of medicinal chemistry (13-07-2023)“…The glycine to cysteine mutation at codon 12 of Kirsten rat sarcoma (KRAS) represents an Achilles heel that has now rendered this important GTPase druggable…”
Get full text
Journal Article -
6
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS G12C
Published in Journal of medicinal chemistry (12-05-2022)“…KRAS is an archetypal high-value intractable oncology drug target. The glycine to cysteine mutation at codon 12 represents an Achilles heel that has now…”
Get full text
Journal Article -
7
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C
Published in Journal of medicinal chemistry (12-05-2022)“…KRAS is an archetypal high-value intractable oncology drug target. The glycine to cysteine mutation at codon 12 represents an Achilles heel that has now…”
Get full text
Journal Article -
8
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS G12C
Published in Journal of medicinal chemistry (14-05-2020)“…Attempts to directly drug the important oncogene KRAS have met with limited success despite numerous efforts across industry and academia. The KRAS mutant…”
Get full text
Journal Article -
9
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
Published in Journal of medicinal chemistry (14-05-2020)“…Attempts to directly drug the important oncogene KRAS have met with limited success despite numerous efforts across industry and academia. The KRASG12C mutant…”
Get full text
Journal Article